omeprazole has been researched along with gsk1325756 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ambery, CL; Bloomer, JC; Connolly, P; Lazaar, AL; Miller, BE; Mistry, S; Sanderson, D; Shreeves, T; Smart, K; Smith, R | 1 |
Bloomer, JC; Carpenter, DC; Connolly, P; Cooray, H; Lazaar, AL; Miller, BE; Mistry, S; Smart, K; Tal-Singer, R | 1 |
Ambery, C; Bloomer, J; Lazaar, AL; Leidy, N; Miller, BE; Tabberer, M; Tal-Singer, R; Watz, H; Yonchuk, J | 1 |
3 trial(s) available for omeprazole and gsk1325756
Article | Year |
---|---|
The pharmacokinetics of conventional and bioenhanced tablet formulations of danirixin (GSK1325756) following oral administration in healthy, elderly, human volunteers.
Topics: Administration, Oral; Age Factors; Aged; Biological Availability; Chemistry, Pharmaceutical; Cross-Over Studies; Drug Interactions; England; Fasting; Female; Healthy Volunteers; Humans; Hydrogen-Ion Concentration; Male; Omeprazole; Piperidines; Postprandial Period; Proton Pump Inhibitors; Respiratory System Agents; Solubility; Sulfones; Tablets | 2014 |
The pharmacokinetics and pharmacodynamics of danirixin (GSK1325756)--a selective CXCR2 antagonist --in healthy adult subjects.
Topics: Adolescent; Adult; Age Factors; Aged; Anti-Inflammatory Agents, Non-Steroidal; CD11b Antigen; Chemokine CXCL1; Dose-Response Relationship, Drug; Double-Blind Method; Food; Healthy Volunteers; Humans; Male; Middle Aged; Neutrophils; Omeprazole; Piperidines; Receptors, Interleukin-8B; Sulfones; Young Adult | 2015 |
Effect of the CXCR2 antagonist danirixin on symptoms and health status in COPD.
Topics: Administration, Oral; Aged; Female; Health Status; Humans; Male; Middle Aged; Omeprazole; Piperidines; Pulmonary Disease, Chronic Obstructive; Receptors, Interleukin-8B; Sulfones; Treatment Outcome | 2018 |